Literature DB >> 7161330

Determination of midazolam and two metabolites of midazolam in human plasma by gas chromatography--negative chemical-ionization mass spectrometry.

F Rubio, B J Miwa, W A Garland.   

Abstract

A method is described for measuring midazolam, a new anesthesia induction agent and hypnotic, and its hydroxymethyl and desmethyl metabolites in human plasma. Deuterated analogues of each compound are added to plasma as internal standards. The compounds are extracted from plasma with benzene containing 20% 1,2-dichloroethane and after removal of the extracting solvent are dissolved in a solution of bis-(trimethylsilyl)acetamide and acetonitrile. An aliquot of this solution is analyzed by gas chromatography--mass spectrometry with the mass spectrometer set to monitor in the gas chromatographic effluent the M.- ions of drug, metabolites and internal standards generated by methane electron-capture negative chemical ionization. For all three compounds, the limit of quantitation is 1 ng ml-1, and the precision (relative standard deviation) at a concentration of 5 ng ml-1 is less than 6%. Measurable amounts of the hydroxymethyl, but not the desmethyl, metabolite of midazolam could be found in the plasma of humans given either an intravenous or an oral dose of midazolam maleate.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7161330     DOI: 10.1016/s0378-4347(00)81742-9

Source DB:  PubMed          Journal:  J Chromatogr


  8 in total

1.  Increased volume of distribution prolongs midazolam half-life.

Authors:  R J Wills; K C Khoo; P P Soni; I H Patel
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

2.  Dose dependent pharmacokinetics of midazolam.

Authors:  L D Bornemann; B H Min; T Crews; M M Rees; H P Blumenthal; W A Colburn; I H Patel
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 3.  Midazolam: a new drug for intravenous sedation.

Authors:  J I Midtling
Journal:  Anesth Prog       Date:  1987 May-Jun

Review 4.  Pharmacokinetics of the newer benzodiazepines.

Authors:  P D Garzone; P D Kroboth
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

5.  The pharmacokinetics of midazolam in patients with congestive heart failure.

Authors:  I H Patel; P P Soni; E K Fukuda; D F Smith; C V Leier; H Boudoulas
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

Review 6.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

7.  Sedative and ventilatory effects of midazolam infusion: effect of flumazenil reversal.

Authors:  C T Mora; M Torjman; P F White
Journal:  Can J Anaesth       Date:  1995-08       Impact factor: 5.063

8.  Midazolam pharmacokinetics following intravenous and buccal administration.

Authors:  R Schwagmeier; S Alincic; H W Striebel
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.